← Back to Clinical Trials
Recruiting NCT07040449

Stress Trajectories and Anhedonia in Adolescence Research Study

Trial Parameters

Condition Anhedonia
Sponsor University of North Carolina, Chapel Hill
Study Type INTERVENTIONAL
Phase N/A
Enrollment 192
Sex ALL
Min Age 13 Years
Max Age 15 Years
Start Date 2025-03-12
Completion 2030-02
Interventions
Montreal Imaging Stress TaskTrier Social Stress Test for Children

Brief Summary

This project will examine how multiple biological measures from the brain and the body's stress response system contribute to anhedonia (the loss of pleasure) in adolescence. The goal of this project is to see if it is possible to combine these biological measures to describe different patterns of activity in the brain and body that adolescents may have in response to stress. The main question this study aims to answer is whether different patterns of activity in the brain and body are related to whether adolescents develop anhedonia and how high or low levels of anhedonia are over time. This study will enroll 192 adolescents who are between 13 and 15 years. Adolescents will complete tasks three times: at the beginning of the study, 10 months after that, and then 10 months after that. In total, they will be part of the study for 20 months. At each time, adolescents will complete surveys, provide samples of spit to measure hormones and provide pictures of their brain to measure brain activity, participate in mildly stressful tasks, and complete different activities that measure how they think. The investigators will also ask each adolescent's parent or legal guardian to answer some surveys about themselves and their child.

Eligibility Criteria

Inclusion Criteria: * Age 13-15 years old at study entry * Ability to understand and sign an assent form * Meets study hearing and vision requirements Exclusion Criteria: * Current use of antipsychotic medication * Current use of medications that would interfere with cardiovascular or endocrine assessments * Metal in the body or other MRI exclusion * Central nervous system disorder or brain injury that could confound brain imaging evaluations * Presence of a medical condition that would interfere with cardiovascular or endocrine assessments * Impaired intellectual functioning * Diagnosed with a neurodevelopmental disability

Related Trials